Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Pfizer announces not to split into two

      Pfizer announces not to split into two

      savita thakur thakur28 Sept 2016 4:28 AM
      U.S. drugmaker Pfizer Inc said it had decided not to separate into two publicly traded companies at this time.Pfizer has for several years weighed...
      Sanofi gets 43 million dollar US funding to spur Zika vaccine development

      Sanofi gets 43 million dollar US funding to spur Zika vaccine development

      savita thakur thakur28 Sept 2016 4:28 AM
      Sanofi SA said the U.S. Department of Health and Human Services approved $43.18 million in funding to accelerate the development of a Zika vaccine, as...
      Ajanta Pharma Announces Launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension

      Ajanta Pharma Announces Launch of Omeprazole and Sodium Bicarbonate Powder for Oral Suspension

      savita thakur thakur28 Sept 2016 4:27 AM
      Ajanta Pharma USA Inc., a wholly owned subsidiary of Ajanta Pharma Ltd, announces the launch of Omeprazole and Sodium Bicarbonate Powder for Oral...
      Pfizer concludes Rs 110 cr deal with Piramal Enterprises

      Pfizer concludes Rs 110 cr deal with Piramal Enterprises

      savita thakur thakur27 Sept 2016 10:45 AM
      New Delhi : Drug maker Pfizer said it has completed the process of transferring four products to Mumbai-based Piramal Enterprises after getting...
      FDA Approves STELARA-ustekinumab For Treatment of Active Crohns Disease

      FDA Approves STELARA-ustekinumab For Treatment of Active Crohn's Disease

      savita thakur thakur27 Sept 2016 6:30 AM
      Janssen Biotech, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) for the treatment of moderately...
      Suven gets 2 patents for molecules targeting CNS disorder

      Suven gets 2 patents for molecules targeting CNS disorder

      savita thakur thakur27 Sept 2016 6:28 AM
      New Delhi : Drug firm Suven Life Sciences has been granted two product patents, one each in India and Japan, for molecules to be developed for...
      Marksans Pharma gets USFDA clearance for allergy drug

      Marksans Pharma gets USFDA clearance for allergy drug

      savita thakur thakur27 Sept 2016 6:28 AM
      New Delhi : Marksans Pharma has received approval from the US health regulator for loratadine liquid filled capsules, used for treatment of allergies,...
      Sanofi may win US approval of 3 billion dollar eczema drug by March

      Sanofi may win US approval of 3 billion dollar eczema drug by March

      savita thakur thakur27 Sept 2016 6:19 AM
      French drugmaker Sanofi and its U.S. partner Regeneron Pharmaceuticals could win U.S. approval for their keenly awaited new eczema drug dupilumab,...
      Indian origin doctor offers UKs first ORDER a DADDY app

      Indian origin doctor offers UKs first ORDER a DADDY app

      savita thakur thakur26 Sept 2016 6:05 AM
      London : An Indian origin doctor from a UK sperm bank has launched a new mobile app for women who can browse and pick the right candidate online to...
      Novartiss Zykadia gets positive results, faces Roche pressure

      Novartis's Zykadia gets positive results, faces Roche pressure

      savita thakur thakur26 Sept 2016 6:05 AM
      Zurich : Novartis's Zykadia drug performed well against a rare form of lung cancer, the Swiss company said, citing a study it hopes will help it win...
      FDA approves lower cost alternative to biotech drug Humira

      FDA approves lower cost alternative to biotech drug Humira

      savita thakur thakur26 Sept 2016 6:04 AM
      Federal regulators approved the first alternative version of the second-best selling drug in the world, Humira, the blockbuster injection used to...
      Indian drug formulation market grew at 15.3 percent in August: Report

      Indian drug formulation market grew at 15.3 percent in August: Report

      savita thakur thakur26 Sept 2016 6:04 AM
      Mumbai : The domestic formulation drug market grew by 15.3 per cent in August to Rs 9,643 crore over the corresponding month last year.The growth was...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok